Role of Novel ILR in the Management of PVCs
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorKansas City Heart Rhythm Research Foundation
About this trial
This prospective, observational study is a single center clinical registry of patients referred for management of symptomatic or asymptomatic Premature Ventricular Contractions (PVCs). Subjects will be followed through 12 months. The study will enroll approximately 50 patients.
Eligibility criteria
Qualifiers
Patients > 18 years of age
Have a Medtronic LINQ II ILR
Willing and able to give written informed consent
Disqualifiers
History of myocardial infarction
Significant flow-limiting coronary artery disease (≥50% stenosis) on invasive coronary angiography or Computed tomography angiography (CTA).
History of cardiac arrest
With existing implantable defibrillators
Trial design
Treatments tested in this trial
- Monitoring of patients presenting with PVCs
Treatment groups
50 Participants
are divided into 1 treatment groupLocations
6Kansas City Heart Rhythm Institute - Roe Clinic66211, Overland ParkKansas, United States
Overland Park Regional Medical Center66215, Overland ParkKansas, United States
Centerpoint Medical Center64057, IndependenceMissouri, United States
Centerpoint Medical Center Clinic64057, IndependenceMissouri, United States
Sponsors and collaborators
Kansas City Heart Rhythm Research Foundation
Lead sponsor
Source ClinicalTrials.gov